Work

Pcn149 - Cost-effectiveness of Brca1/2 Mutation Profiling to Target Olaparib Use in Patients With Metastatic Breast Cancer in Japan

Year: 2018

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2018.09.232

Authors: S. Saito, K. Nakazawa, M. Nagahashi, K. Akazawa

Institutions: Niigata University of Health and Welfare, Niigata University, Niigata University Medical and Dental Hospital

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2906640593

Cites:

Cited by:

Related to: 10